Download PDF
CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2022; 14(02): 046-049
DOI: 10.1055/s-0042-1755131
Viewpoint

Status of Cancer Survivorship Care: Should We Not Improve?

Ramanujam Anugonda Singarachari
1   Department of Medicine, Yas Clinic Khalifa City, Khalifa City, Abu Dhabi, United Arab Emirates
› Author Affiliations
Funding and sponsorship None.
› Further Information
Also available at
  Permissions and Reprints

Cancer mortality has significantly decreased due to screening, early detection, improved diagnostics, treatments, and supportive care.[1] Worldwide, an estimated 28.4 million new cancer cases are projected to occur in 2040.[2] Cancer survival in the United Kingdom has doubled in the past 40 years from 24 to 50%.[3] By 2040, we expect around 26 million cancer survivors in the United States of America.[4] The total global cancer survivor population, including Asia, could be over several million. Undoubtedly, every healthcare provider will encounter a cancer survivor in their practice. The care of cancer survivors is often uncoordinated, incomplete, and tends to be fragmentary. Significant improvements in cancer survivor care are necessary in most parts of the developing world by implementing the core essentials of cancer survivorship care, such as ASCO, ESMO, National Academies of Sciences, Engineering and Medicine, and National Cancer Survivorship Resource Center (The Survivorship Center).[5] [6] [7]

We summarize this topic through a set of questions and answers. The core essentials of cancer survivorship care will be outlined, and finally, we will discuss a few methods of its implementation in our region.

Compliance with Ethical Principles

No ethical approval is required.


Data Availability

Not applicable.




Publication History

Article published online:
14 July 2022

© 2022. The Libyan Authority of Scientific Research and Technology and the Libyan Biotechnology Research Center. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India